产品封面图

K7M2 wt [K7M2-WT]

收藏
  • 询价
  • 2025年11月21日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 物种来源

      小鼠

    • 是否是肿瘤细胞

      0

    • 细胞形态

      其他

    • 细胞类型

      其他细胞类型

    • 器官来源

    • 库存

      大量

    • 运输方式

      冻存运输

    • 相关疾病

      骨肉瘤

    • ATCC Number

      CRL-2836™

    • 生长状态

      贴壁生长

    • 品系

      BALB/c

    Designations: K7M2 wt [K7M2-WT]
    Depositors:  C Khanna
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Mus musculus
    Morphology: osteoblast

    Source: Strain: BALB/c
    Organ: bone
    Disease: osteosarcoma
    Derived from metastatic site: lung
    Cell Type: osteoblast;
    Cellular Products: decorin [89453 ]
    secreted phosphoprotein 1 (osteopontin) [89453 ]
    villin 2 (ezrin) [89454 ]
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Isolation: Isolation date: 1998 (The K7M2 wt cell line was derived by intra-osseous injection of the K7 murine osteosarcoma cell line to the proximal tibia of a BALB/c mouse. The resultant primary tumor spontaneously metastasized to the lungs. A pulmonary metastasis was removed from the lung and then surgically implanted to a paraosteal tibial muscle flap of a na�ve mouse. This cycle of implantation of pulmonary metastasis to paraosteal tibial muscle flap sites was repeated, resulting in the K7M2 primary tumor. This tumor was dissociated to a single cell suspension to create the K7M2 wt cell line)
    Applications: tumor model
    Tumorigenic: Yes
    Comments: Antigen Expression: CD31 + [PubMed:1315100]
    Products: factor VIII [PubMed: 11315100]; integrin binding sialoprotein (BSP) [PubMed11315100]; biglyan [PubMed: 11315100]; decorrin [PubMed:1315100]; villin 2 (ezrin) [PubMed: 11325848].
    Expression of bone sialoprotein, biglyan, decorrin, and osteopontin is suggestive of bone lineage cells.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
      An inoculum of 6 X 10(3) to 8 X 10(3) viable cells/cm2 is recommended.
    6. Incubate cultures at 37�C.

    Interval: Maintain cultures at a cell concentration between 5 X 10(3) and 3 X 10(5) cells/cm2
    Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended
    Medium Renewal: Two to three times weekly
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Doubling Time: 31 hours
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
    recommended serum:ATCC 30-2020
    derivative:ATCC CRL-2837
    References: 89453: Khanna C, et al. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin. Exp. Metastasis 18: 261-271, 2000. PubMed: 11315100
    89454: Khanna C, et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 61: 3750-3759, 2001. PubMed: 11325848
    89468: Khanna C, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat. Med. 10: 182-186, 2004. PubMed: 14704791

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • 【求助】WT高表达,IHC弱表达,SOS

      expolee 大家好,最近检测肿瘤markerA表达,qPCR和WT检测肿瘤细胞是高表达的,收集病人标本做成组织芯片后免疫组化检测则是:肿瘤组织弱表达、正常组织弱表达,怎么解释呢?尽管IHC只是定位,可弱表达的话有没有再往下做下去的意义了?欢迎大家发言,谢谢! shylook 组织标本保存问题 IHC是否规范 是否摸过抗体使用浓度 包括二抗 一抗能能否做IHC expolee

    • Enzyme Kinetics assay of the WT

      To assay 17 b-HSD activity in lysates, cells were harvested 48h after transfection using PBS Enzyme Free Cell Dissociation Solution ( specialty Media Inc., Lavellette, NJ), frozen on dry ice and stored at -80 C. Cell pellets were thawed

    • 【求助】请教一下各位大虾:质粒pACYC184和pBRM-Wt的具体结构是怎样的呢,从哪可以得到,谢谢!

      西点6688 请教一下各位大虾:质粒pACYC184和pBRM-Wt的具体结构是怎样的呢,谢谢! slytjiaofei http://genome-www.stanford.edu/vectordb/vector.html 自己查查吧!!! lastone9853 这两个质粒pACYC184和pBRM-Wt的图谱,序列等可以在网上查到,我这有这两个载体,可以快

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥800
    上海雅吉生物科技有限公司
    2025年07月08日询价
    ¥800
    上海彩佑实业有限公司
    2024年04月07日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年07月12日询价
    ¥1480
    上海酶研生物科技有限公司
    2026年01月12日询价
    ¥1300
    上海匹拓生物科技有限公司
    2026年01月26日询价
    K7M2 wt [K7M2-WT]
    询价